Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Chronimed, Inc. (NasdaqNM:CHMDE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
10900 Red Circle Drive
Minnetonka, MN 55343
Phone: (952) 979-3600
Fax: (952) 979-3969
Email: info@chronimed.com
Employees (last reported count): 280
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Services
 ·Industry: Retail (Drugs)
Company Websites
 ·Home Page
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 19%
·Over the last 6 months:
 · 8 insider buys; 13.0K shares (0.6% of insider shares)
 · one insider sell; 1,000  shares
·Institutional: 49% (60% of float)
(48 institutions)
·Net Inst. Selling: 172.0K shares (+2.95%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Chronimed, Inc. is a disease-focused company specializing in specialty pharmacy distribution for people with chronic health conditions. The Company distributes pharmaceuticals and provides specialized patient management services nationwide for people with long-term chronic conditions such as organ transplants, HIV/AIDS, diabetes, and diseases treated with biotech injectable medications. Chronimed works directly with patients, providers, and payors to improve clinical and cost-of-care outcomes. On March 13, 2000, Chronimed announced its intention to spin off its Diagnostic Products business (to be named MEDgenesis Inc.) to shareholders, contingent upon the satisfaction of various conditions.
More from Market Guide: Expanded Business Description

Financial Summary
Chronimed, Inc. is a disease-focused company specializing in specialty pharmacy distribution for people with chronic health conditions. For the 39 weeks ended 3/30/01, revenues rose 29% to $214.4 million. Net income from continuing operations totalled $2.8 million, vs. a loss of $1.7 million. Revenues benefited from the acquisition of APP and new patients from the Biotech Injectibles contract with Aetna. Net income reflects the absence of a $5.5 million write-off.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Henry Blissenbach, 58
Chairman, CEO
$296K
Stephen Ritter, 42
Sr. VP, Mail-Order
--  
Gregory Keane, 45
VP, CFO, Treasurer
230K
Patrick Taffe, 48
VP, CIO
241K
Shawn Featherston, 47
VP, HR
185K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CHMDEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 26-June-2001
$3.95 
Recent Price$4.60 
52-Week High
on 22-Feb-2001
$15.00 
Beta0.15 
Daily Volume (3-month avg)96.4K
Daily Volume (10-day avg)23.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-34.3%
52-Week Change
relative to S&P500
-11.8%
Share-Related Items
Market Capitalization$56.6M
Shares Outstanding12.3M
Float10.0M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 22-Feb-1994
Per-Share Data
Book Value (mrq*)$6.83 
Earnings (ttm)$0.27 
Earnings (mrq)$0.08 
Sales (ttm)$22.26 
Cash (mrq*)$0.99 
Valuation Ratios
Price/Book (mrq*)0.67 
Price/Earnings (ttm)17.16 
Price/Sales (ttm)0.21 
Income Statements
Sales (ttm)$273.5M
EBITDA (ttm*)$9.76M
Income available to common (ttm)$3.29M
Profitability
Profit Margin (ttm)1.2%
Operating Margin (ttm)2.1%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
30-Mar-2001
Most recent quarter
(flash earnings)
31-Mar-2001
Management Effectiveness
Return on Assets (ttm)3.67%
Return on Equity (ttm)4.59%
Financial Strength
Current Ratio (mrq*)3.07 
Debt/Equity (mrq*)0 
Total Cash (mrq)$12.2M
Short Interest
As of 8-Aug-2001
Shares Short25.0K
Percent of Float0.2%
Shares Short
(Prior Month)
28.0K
Short Ratio0.58 
Daily Volume43.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001, except mrq*/ttm* items as of 30-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.